Medicines Australia chair Dr Anna Lavelle appears genuinely affronted and described her personal disappointment over what she called the "very disingenuous" approach to the implementation of the new PBS pricing framework. …
Not too late to gain a proper understanding of what is in these agreements
September 14, 2022 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Uniseed names Alastair Hick as new CEO to lead next phase of growth
October 29, 2025 - - Australian Biotech -
Australian-based world-first RNA trial offers new hope for lupus patients
October 29, 2025 - - Australian Biotech -
Australians with chronic disease call for stronger investment in PBS
October 29, 2025 - - Latest News -
Australia launches first clinical and commercial-scale viral vector manufacturing facility
October 28, 2025 - - Latest News -
Myrio Therapeutics partners with leading US research institutions to advance T cell immunotherapies for solid tumours
October 28, 2025 - - Australian Biotech -
MTPConnect signs cooperation agreement with Saudi Ministry of Health to boost life sciences collaboration
October 28, 2025 - - Australian Biotech -
ObvioHealth partners with Vaxxas to advance needle-free vaccination through digital clinical trials
October 28, 2025 - - Australian Biotech